Systematic Coronary Risk Evaluation
3 papers1 finding
- Humans2
Effects
1Klotho
no changein humans1
1 study
Klotho
no changein humans1
Systematic Coronary Risk Evaluation has no effect on Klotho in humans (p = 0.974).
“In the AS group, Klotho levels were observed as 0.73 in the low-risk group, 0.60 in the moderate-risk group, and 0.61 in the high-risk group (p = 0.974).”
HumansAnkylosing Spondylitis patients
Journal of clinical medicine24 Dec 2025
Latest
11 in 12 monthsAtherosclerosis
Inflammation and lipoprotein(a) as predictors of cardiovascular events across baseline risk levels - results from the UK Biobank
Cohort study of 241,010 peopleLipoprotein
Journal of Geriatric Cardiology
Sex disparities in LDL-C target achievement among older adults receiving statin therapy
Cross-sectional study of 360 peoplePopulations
Cardiovascular Diagnosis and Therapy
Biomarkers in plasma and extracellular vesicles for early detection of asymptomatic ischemic heart disease: a retrospective case-control study
Case-control study in peopleIschemic heart disease
European Heart Journal
Development and external validation of the SCORE2 models in Latin America and the Caribbean (SCORE2-LAC) to estimate 10-year cardiovascular disease risk
Cohort study of 40,237,152 peopleCardiovascular disease
JACC Cardiovascular Imaging
Incremental Predictive Value of Deep Learning-Quantified Coronary Atherosclerotic Volume: A SCAPIS Cohort Analysis
Cohort study of 23,314 peopleBiomarkers
Journal of General Internal Medicine
Cardiovascular Risk Prediction in Africa: Why Global Tools Fail and What We Must Do
CommentaryCardiovascular disease
Circulation Genomic and Precision Medicine
Multiomics for Risk Stratification in Atherosclerotic Cardiovascular Disease
JMIR Public Health and Surveillance
Interactive Digital Visualization Counseling for Lifestyle Change in Patients at Risk of Cardiovascular Diseases: Randomized Controlled Trial
Randomised trial in 119 peopleInterventions